Market Research Report
Acute Coronary Syndrome
|Published by||Global Industry Analysts, Inc.||Product code||997864|
|Published||Content info||156 Pages
Delivery time: 1-2 business days
|Acute Coronary Syndrome|
|Published: April 1, 2021||Content info: 156 Pages||
Global Acute Coronary Syndrome Market to Reach $67.7 Billion by 2027
Amid the COVID-19 crisis, the global market for Acute Coronary Syndrome estimated at US$30.3 Billion in the year 2020, is projected to reach a revised size of US$67.7 Billion by 2027, growing at a CAGR of 12.2% over the period 2020-2027.
The U.S. Market is Estimated at $8.2 Billion, While China is Forecast to Grow at 16% CAGR
The Acute Coronary Syndrome market in the U.S. is estimated at US$8.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$14.8 Billion by the year 2027 trailing a CAGR of 16% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.6% and 10.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.
Select Competitors (Total 60 Featured) -